This could also help build a prognostic model so that the groups characterized by unique cognitive decline patterns can be predicted using the selected corresponding features like participants demographics, APOE genotype, cardiovascular risk factors, and other existing AD or dementia biomarkers. The gene discussed is APOE; the disease is dementia.